GO:2000341 regulation of chemokine (C-X-C motif) ligand 2 production: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000341 describes any process that modulates the frequency, rate or extent of production of chemokine (C-X-C motif) ligand 2 (CXCL2), also known as MIP-2 or SCYB2.
• CXCL2 is a neutrophil-recruiting chemokine whose expression is controlled transcriptionally, for example by the Fli-1 transcription factor.
• CXCL2 production is embedded in inflammatory circuits: alveolar epithelial mitochondrial fatty acid oxidation mitigates neutrophilic inflammation partly by regulating chemokine output.
• In tumors, CXCL2 can be induced downstream of RAB31 to drive CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation.
• Neutrophil ADAM10 modulates adhesion and chemokine signaling in ARDS, linking CXCL2 regulation to acute lung injury.
• Studying GO:2000341 requires combining perturbation (CRISPR KO, knock-in, overexpression) with cytokine readouts such as ELISA, RNA-seq and functional chemotaxis assays.
Description
GO:2000341, regulation of chemokine (C-X-C motif) ligand 2 production, is a biological_process term that captures all molecular events controlling how much CXCL2 (also called MIP-2 or SCYB2) a cell produces and releases. CXCL2 is a C-X-C motif chemokine that acts as a chemoattractant for neutrophils, and its abundance must be tightly regulated to allow effective host defense without causing excessive tissue damage. Because CXCL2 sits at the intersection of innate immunity, epithelial barrier biology and tumor microenvironment remodeling, researchers in inflammation, lung injury and cancer immunology routinely need to quantify and perturb this process. The term is therefore not about a single gene but about a regulatory node: transcription factors, signaling adaptors, vesicle trafficking proteins and proteases can all modulate CXCL2 production. Understanding GO:2000341 helps investigators design experiments that distinguish upstream inducers from downstream effectors of neutrophilic inflammation.
regulation of chemokine (C-X-C motif) ligand 2 production At A Glance
| GO ID | GO:2000341 |
|---|---|
| GO term | regulation of chemokine (C-X-C motif) ligand 2 production |
| Ontology | biological_process |
| Definition | Any process that modulates the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production. |
| Synonym | regulation of CXCL2 production; regulation of MIP-2 production; regulation of MIP2 production; regulation of SCYB2 production; regulation of CCL2 secretion (historical synonym) |
| Major function | Controls the amount of CXCL2/MIP-2 available to recruit neutrophils and shape inflammatory microenvironments. |
| Representative regulators | Fli-1 transcription factor, RAB31, ADAM10, mitochondrial fatty acid oxidation pathways. |
| Disease relevance | Acute lung injury/ARDS, atherosclerosis, colorectal cancer and other inflammation-driven conditions. |
| Typical readouts | CXCL2 ELISA, CXCL2 mRNA by qPCR/RNA-seq, neutrophil chemotaxis assays. |
What Is GO:2000341?
In our own words, GO:2000341 encompasses any biological process that changes the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production. It includes transcriptional activation or repression of the CXCL2 gene, post-transcriptional control of CXCL2 mRNA, translation and secretion of the CXCL2 protein, and any signaling event that indirectly alters the amount of CXCL2 made by a cell. The term is deliberately broad: it does not specify a single mechanism, cell type or stimulus, but it provides a controlled vocabulary for annotating experiments in which CXCL2 output is measured and manipulated.
Why Is regulation of chemokine (C-X-C motif) ligand 2 production Important in Cell Biology?
GO:2000341 matters because CXCL2 is one of the principal neutrophil chemoattractants, and the amount of CXCL2 produced determines whether an inflammatory response is protective or destructive. In lung injury, alveolar epithelial cells mitigate neutrophilic inflammation through mitochondrial fatty acid oxidation, a process that intersects with chemokine regulation. In atherosclerosis, blockade of the interleukin-1 receptor accessory protein limits plaque inflammation and reduces chemokine-driven myeloid recruitment. In cancer, RAB31 orchestrates CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation, showing that regulation of CXCL2 production can be co-opted by tumors. Consequently, tools that measure and perturb GO:2000341 are central to mechanistic immunology and to translational studies of inflammatory disease.
• CXCL2 is a major neutrophil chemoattractant, so its production rate directly sets the intensity of neutrophilic inflammation.
• The Fli-1 transcription factor is a critical regulator of CXCL2 expression, providing a defined entry point for transcriptional studies.
• Alveolar epithelial mitochondrial fatty acid oxidation mitigates neutrophilic inflammation in lung injury, linking metabolism to chemokine control.
• RAB31-driven CXCL2 production supports CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation in colorectal cancer.
• Neutrophil ADAM10 promotes migration and inflammation in ARDS by modulating adhesion and chemokine signaling.
• Interleukin-1 receptor accessory protein blockade limits atherosclerosis and reduces plaque inflammation, a setting where chemokine regulation is therapeutically relevant.
• Keratinocyte autophagy enables keratinocyte and fibroblast activation and facilitates wound healing, a process in which chemokine production is a functional output.
• The anti-inflammatory peptide catestatin blocks chemotaxis, illustrating that chemokine-driven migration can be pharmacologically interrupted.
• CXCL1, a close C-X-C family member, sustains breast cancer stem cell self-renewal and immune escape, highlighting family-level relevance in oncology.
• GO:2000341 provides a standardized annotation target for CRISPR screens and cytokine profiling experiments.
What Happens During regulation of chemokine (C-X-C motif) ligand 2 production?
Transcriptional control of CXCL2
In simple terms: The cell decides how much CXCL2 mRNA to make by turning the CXCL2 gene on or off.
The first layer of regulation is transcription. The Fli-1 transcription factor is a critical regulator that controls expression of chemokine C-X-C motif ligand 2 (CXCL2), directly linking a specific DNA-binding protein to CXCL2 output. In lung injury models, alveolar epithelial cells mitigate neutrophilic inflammation through regulation of mitochondrial fatty acid oxidation, a metabolic program that influences the inflammatory transcriptional state and chemokine production. In tumors, RAB31 orchestrates CXCL2-CXCR4-mediated neutrophil recruitment, implying that upstream trafficking signals can feed into CXCL2 transcriptional programs.
Post-transcriptional and secretory control
In simple terms: Even after mRNA is made, the cell can still adjust how much CXCL2 protein is released.
Regulation of production is not limited to transcription. Secretory and membrane-trafficking machinery can alter how much CXCL2 reaches the extracellular space. Neutrophil ADAM10 promotes migration and inflammation in ARDS by modulating adhesion and chemokine signaling, indicating that proteolytic and adhesion-dependent events shape chemokine availability. The anti-inflammatory peptide catestatin blocks chemotaxis, showing that extracellular signals can interrupt chemokine-driven recruitment even when chemokine is present. Together these observations support a multi-step view of GO:2000341 in which transcription, translation and secretion all contribute.
Integration with inflammatory signaling networks
In simple terms: CXCL2 production is wired into the broader inflammatory alarm system of the cell.
CXCL2 production is embedded in cytokine and innate immune signaling. Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation, a phenotype consistent with reduced chemokine-driven myeloid recruitment. Keratinocyte autophagy enables activation of keratinocytes and fibroblasts and facilitates wound healing, a reparative process in which chemokine production is a functional output. These studies place GO:2000341 within signaling networks that convert tissue stress into neutrophil recruitment.
Consequences for neutrophil recruitment
In simple terms: The amount of CXCL2 made determines how many neutrophils arrive.
The functional endpoint of GO:2000341 is neutrophil recruitment. RAB31 orchestrates CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation in colorectal cancer, directly connecting regulated CXCL2 production to a defined cellular outcome. Neutrophil ADAM10 promotes migration and inflammation in ARDS by modulating adhesion and chemokine signaling, further linking chemokine regulation to neutrophil behavior in acute lung injury. Alveolar epithelial mitochondrial fatty acid oxidation mitigates neutrophilic inflammation in lung injury, showing that metabolic control of chemokine production can dampen neutrophil influx. The anti-inflammatory peptide catestatin blocks chemotaxis, providing a pharmacological example of interrupting this endpoint.
CXCL2 in tumor and stem-cell microenvironments
In simple terms: Tumors can hijack CXCL2 regulation to build a supportive niche.
Beyond acute inflammation, regulation of CXCL2 production contributes to tumor biology. RAB31 orchestrates CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation in colorectal cancer, demonstrating that CXCL2 regulation can be co-opted for angiogenesis and immune modulation. The related chemokine CXCL1 sustains breast cancer stem cell self-renewal and promotes tumor progression and immune escape programs, illustrating that C-X-C family chemokines are functionally important in oncology. These findings motivate studying GO:2000341 in cancer models as well as in classical inflammation settings.
Key Genes Involved in GO:2000341 regulation of chemokine (C-X-C motif) ligand 2 production
The following genes and proteins have been experimentally linked to regulation of CXCL2 production or to its downstream neutrophil-recruitment consequences in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCL2 | Encodes the C-X-C motif chemokine ligand 2 (MIP-2, SCYB2) whose production is the object of GO:2000341 | Core readout gene for qPCR, ELISA and RNA-seq in inflammation studies |
| FLI1 | Fli-1 transcription factor is a critical regulator controlling CXCL2 expression | Transcription-factor perturbation to test transcriptional control of CXCL2 |
| RAB31 | Orchestrates CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation | Trafficking-gene knockout to test tumor neutrophil recruitment |
| ADAM10 | Neutrophil ADAM10 promotes migration and inflammation in ARDS by modulating adhesion and chemokine signaling | Protease perturbation in acute lung injury models |
| CXCR4 | Receptor mediating CXCL2-CXCR4 signaling in neutrophil recruitment | Receptor blockade or knockout to test downstream recruitment |
| IL1RAP | Interleukin-1 receptor accessory protein; its blockade limits atherosclerosis and reduces plaque inflammation | Target for anti-inflammatory intervention in atherosclerosis models |
| CXCL1 | C-X-C family chemokine that sustains breast cancer stem cell self-renewal and immune escape | Family-level comparison in cancer stem cell assays |
| CST (catestatin peptide) | Anti-inflammatory peptide that blocks chemotaxis | Pharmacological tool to interrupt chemokine-driven migration |
| Mitochondrial FAO enzymes | Alveolar epithelial mitochondrial fatty acid oxidation mitigates neutrophilic inflammation in lung injury | Metabolic perturbation to test chemokine output in lung injury |
| Autophagy machinery (keratinocytes) | Keratinocyte autophagy enables keratinocyte and fibroblast activation and facilitates wound healing | Autophagy knockout in skin wound models |
| Neutrophil adhesion molecules | Modulate adhesion and chemokine signaling in ARDS | Adhesion perturbation in neutrophil migration assays |
| Inflammatory cytokine receptors | Transduce signals that alter chemokine production | Receptor blockade in atherosclerosis and inflammation models |
| Epithelial metabolic regulators | Link mitochondrial metabolism to neutrophilic inflammation | Epithelial-specific metabolic knockout in lung injury |
| Wound-healing keratinocyte factors | Enable keratinocyte and fibroblast activation during repair | Conditional knockout in skin injury models |
| Tumor microenvironment trafficking proteins | Support proangiogenic niche formation via chemokine recruitment | Xenograft and knockout studies in colorectal cancer |
| Chemotaxis-modulating peptides | Block chemokine-driven migration | Peptide treatment in chemotaxis assays |
How Is regulation of chemokine (C-X-C motif) ligand 2 production Regulated?
Regulation of CXCL2 production is multi-layered. At the transcriptional level, the Fli-1 transcription factor is a critical regulator controlling CXCL2 expression. At the signaling level, interleukin-1 receptor accessory protein blockade limits atherosclerosis and reduces plaque inflammation, indicating that IL-1 family signaling feeds into chemokine regulation. At the metabolic level, alveolar epithelial mitochondrial fatty acid oxidation mitigates neutrophilic inflammation in lung injury, linking cellular metabolism to chemokine output. At the trafficking level, RAB31 orchestrates CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation, showing that vesicle trafficking proteins can control the effective chemokine signal. Finally, neutrophil ADAM10 modulates adhesion and chemokine signaling in ARDS, adding a proteolytic and adhesion-dependent layer of control. These layers can be studied independently with CRISPR perturbation and cytokine readouts.
regulation of chemokine (C-X-C motif) ligand 2 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCL2 | Neutrophilic lung inflammation and ARDS | Lung epithelial knockout or overexpression with CXCL2 ELISA and neutrophil influx readouts |
| IL1RAP | Atherosclerosis and plaque inflammation | ApoE-deficient or LDLR-deficient mouse models with IL1RAP blockade |
| RAB31 | Colorectal cancer neutrophil recruitment and angiogenesis | Xenograft or orthotopic colorectal cancer models with RAB31 knockout |
| FLI1 | Transcriptional control of CXCL2 in inflammation | CRISPR knockout or knockdown of FLI1 with CXCL2 mRNA and protein readouts |
| ADAM10 | ARDS neutrophil migration and inflammation | Neutrophil-specific conditional knockout in acute lung injury models |
Acute lung injury and ARDS
Regulation of CXCL2 production is central to neutrophilic lung inflammation. Alveolar epithelial cells mitigate neutrophilic inflammation in lung injury through regulating mitochondrial fatty acid oxidation, a mechanism that restrains excessive chemokine-driven neutrophil influx. Neutrophil ADAM10 promotes migration and inflammation in ARDS by modulating adhesion and chemokine signaling, directly implicating chemokine regulation in acute respiratory distress syndrome pathology. These studies suggest that therapeutic strategies aimed at GO:2000341 could reduce lung injury without fully abolishing host defense.
Atherosclerosis and vascular inflammation
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation, a phenotype that reflects reduced chemokine-driven myeloid recruitment into the vessel wall. Because CXCL2 is a neutrophil chemoattractant, regulation of its production is a plausible contributor to plaque inflammation, and IL-1 pathway blockade provides a validated experimental handle on this process.
Colorectal cancer and tumor microenvironment
RAB31 orchestrates CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation in colorectal cancer, demonstrating that regulation of CXCL2 production can be co-opted to build a tumor-supportive microenvironment. The related chemokine CXCL1 sustains breast cancer stem cell self-renewal and promotes tumor progression and immune escape programs, reinforcing the idea that C-X-C family chemokines are functionally important in cancer. Targeting GO:2000341 in tumors may therefore disrupt neutrophil recruitment and angiogenesis.
Wound healing and tissue repair
Keratinocyte autophagy enables the activation of keratinocytes and fibroblasts and facilitates wound healing, a reparative process in which chemokine production is a functional output. The anti-inflammatory peptide catestatin blocks chemotaxis, showing that chemokine-driven migration can be pharmacologically modulated during repair. These findings connect GO:2000341 to tissue remodeling as well as to acute inflammation.
From regulation of chemokine (C-X-C motif) ligand 2 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is FLI1 required for CXCL2 transcription? | FLI1 knockout or point-mutation cell lines with CXCL2 mRNA and ELISA readouts |
| Does RAB31 control CXCL2-dependent neutrophil recruitment? | RAB31 knockout tumor cells in xenograft or orthotopic models with neutrophil quantification |
| Does epithelial metabolic perturbation alter CXCL2 production? | Epithelial-specific knockout of mitochondrial fatty acid oxidation genes in lung injury models |
| Does ADAM10 modulate chemokine signaling in neutrophils? | Neutrophil-specific ADAM10 knockout in ARDS models |
| Can IL-1 pathway blockade reduce chemokine-driven plaque inflammation? | IL1RAP blockade in atherosclerosis-prone mouse models |
| Does autophagy in keratinocytes affect chemokine output during repair? | Keratinocyte-specific autophagy knockout in wound healing models |
How to Study the regulation of chemokine (C-X-C motif) ligand 2 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| qPCR | CXCL2 mRNA abundance | Testing transcriptional regulation after FLI1 perturbation |
| RNA-seq | Global transcriptome including CXCL2 and inflammatory genes | Profiling chemokine programs in inflammation models |
| ELISA | Secreted CXCL2 protein | Quantifying production in cell culture supernatants |
| Chemotaxis assay | Neutrophil migration toward chemokine gradients | Testing catestatin or other inhibitors of chemotaxis |
| Flow cytometry | Neutrophil recruitment and activation markers | Quantifying immune cell influx in tumor and lung models |
| CRISPR knockout | Loss-of-function effect on CXCL2 production | Testing FLI1, RAB31, ADAM10 or metabolic genes |
| CRISPR knock-in / overexpression | Gain-of-function or tagged allele effects | Testing sufficiency of candidate regulators |
| In vivo disease models | Phenotypes such as plaque inflammation or lung injury | Translating chemokine regulation to disease outcomes |
Transcript and protein quantification of CXCL2
Because GO:2000341 is defined by the amount of CXCL2 produced, the primary readouts are CXCL2 mRNA and protein. Quantitative PCR and RNA-seq measure transcript abundance, while ELISA measures secreted protein. These approaches have been used to link Fli-1 to CXCL2 expression and to characterize chemokine output in inflammatory models. Combining transcript and protein measurements distinguishes transcriptional from post-transcriptional regulation.
Functional chemotaxis and neutrophil recruitment assays
The biological consequence of CXCL2 production is neutrophil recruitment. Chemotaxis assays and in vivo neutrophil quantification are therefore essential functional endpoints. The anti-inflammatory peptide catestatin blocks chemotaxis, providing a validated assay format for testing whether a perturbation changes chemokine-driven migration. RAB31-dependent CXCL2-CXCR4-mediated neutrophil recruitment has been assessed in tumor models, illustrating how recruitment can be measured in vivo.
CRISPR perturbation combined with cytokine profiling
CRISPR knockout, point mutation, knock-in and overexpression allow causal testing of candidate regulators. For example, FLI1 perturbation can be combined with CXCL2 mRNA and protein readouts to test transcriptional control, while RAB31 knockout can be combined with neutrophil recruitment assays in tumor models. Metabolic and protease candidates such as mitochondrial fatty acid oxidation enzymes and ADAM10 can be perturbed in relevant cell types and their effects on chemokine output measured.
Disease-model integration
To connect GO:2000341 to human disease, perturbations should be tested in disease-relevant models. Atherosclerosis studies using IL1RAP blockade show how chemokine-driven inflammation can be reduced in vivo. Lung injury models with epithelial metabolic perturbation link chemokine regulation to neutrophilic inflammation. Wound healing models with keratinocyte autophagy knockout connect chemokine output to tissue repair. Colorectal cancer models with RAB31 perturbation connect CXCL2 regulation to tumor angiogenesis and immune modulation.
How CRISPR Can Be Used to Study GO:2000341 regulation of chemokine (C-X-C motif) ligand 2 production
Knockout
CRISPR knockout is the most direct way to test whether a candidate gene is required for CXCL2 production. Knocking out FLI1 tests its role as a critical transcriptional regulator of CXCL2. Knocking out RAB31 tests whether trafficking-dependent CXCL2-CXCR4-mediated neutrophil recruitment is preserved. Knocking out ADAM10 in neutrophils tests its role in adhesion and chemokine signaling in ARDS models. Metabolic genes controlling mitochondrial fatty acid oxidation can be knocked out in alveolar epithelial cells to test their effect on neutrophilic inflammation.
Point Mutation
Point mutation models allow separation of specific protein functions from scaffolding or interaction roles. For a transcription factor such as Fli-1, DNA-binding-domain point mutations can distinguish direct CXCL2 promoter regulation from indirect effects. For signaling adaptors in the IL-1 pathway, point mutations can test which domains are required for chemokine-driven plaque inflammation. Point mutations in trafficking proteins such as RAB31 can test whether GTP binding or effector interaction is needed for CXCL2-dependent neutrophil recruitment.
Knock-in
Knock-in models introduce tagged or reporter alleles to track CXCL2 production in real time. A tagged CXCL2 allele enables direct measurement of secreted chemokine and localization studies. Knock-in of disease-associated variants in inflammatory pathway genes can test their effect on chemokine output in relevant cell types. Knock-in reporters for neutrophil-recruitment genes can be combined with tumor models to visualize proangiogenic niche formation.
Overexpression
Overexpression tests sufficiency: if a candidate regulator is overexpressed, does CXCL2 production increase? Overexpressing Fli-1 can test whether it is sufficient to drive CXCL2 expression. Overexpressing RAB31 can test whether it is sufficient to promote CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation. Overexpressing chemokine-family members such as CXCL1 can test their role in stem cell self-renewal and immune escape programs. Overexpression of metabolic regulators can test whether altered mitochondrial fatty acid oxidation changes chemokine output.
How EDITGENE Supports regulation of chemokine (C-X-C motif) ligand 2 production Research
Researchers studying regulation of chemokine (C-X-C motif) ligand 2 production-related genes often need to determine whether a candidate gene is causally involved in controlling CXCL2 output or whether it is merely correlated with an inflammatory phenotype. This requires precise, reproducible genome engineering: knocking out the candidate, introducing defined point mutations, tagging the endogenous locus, or overexpressing the gene in a controlled background. EDITGENE provides these capabilities together with functional readouts and bioinformatic analysis, enabling teams to move from candidate lists to mechanistic conclusions about GO:2000341.
Contact EDITGENE today to design your custom CRISPR model for regulation of chemokine (C-X-C motif) ligand 2 production research.
Frequently Asked Questions About regulation of chemokine (C-X-C motif) ligand 2 production
What is GO:2000341?
GO:2000341 is the Gene Ontology biological_process term for regulation of chemokine (C-X-C motif) ligand 2 production, meaning any process that modulates the frequency, rate or extent of CXCL2 (MIP-2, SCYB2) production.
What genes are involved in regulation of chemokine (C-X-C motif) ligand 2 production?
Verified regulators include the Fli-1 transcription factor, which is a critical regulator of CXCL2 expression, and RAB31, which orchestrates CXCL2-CXCR4-mediated neutrophil recruitment. ADAM10 and mitochondrial fatty acid oxidation pathways also modulate chemokine signaling and neutrophilic inflammation.
Why is CXCL2 production important in inflammation?
CXCL2 is a neutrophil chemoattractant, so its production rate determines how many neutrophils are recruited to a tissue, which is central to both protective immunity and inflammatory tissue damage.
How is CXCL2 production regulated transcriptionally?
The Fli-1 transcription factor is a critical regulator controlling CXCL2 expression, providing a direct transcriptional entry point for regulation of CXCL2 production.
What is the role of RAB31 in CXCL2 biology?
RAB31 orchestrates CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation in colorectal cancer, linking trafficking proteins to chemokine-dependent tumor biology.
How does ADAM10 affect chemokine signaling in ARDS?
Neutrophil ADAM10 promotes migration and inflammation in ARDS by modulating adhesion and chemokine signaling, indicating a role in acute lung injury pathology.
Can CXCL2-driven chemotaxis be blocked pharmacologically?
Yes, the anti-inflammatory peptide catestatin blocks chemotaxis, demonstrating that chemokine-driven migration can be pharmacologically interrupted.
What experimental methods are used to study regulation of CXCL2 production?
Common methods include qPCR and RNA-seq for CXCL2 mRNA, ELISA for secreted protein, chemotaxis assays for function, and CRISPR knockout or overexpression for causal testing.
Is regulation of CXCL2 production relevant to cancer?
Yes, RAB31-dependent CXCL2-CXCR4 signaling supports neutrophil recruitment and proangiogenic niche formation in colorectal cancer, and the related chemokine CXCL1 sustains breast cancer stem cell self-renewal and immune escape.
How can CRISPR help study GO:2000341?
CRISPR knockout, point mutation, knock-in and overexpression allow researchers to test whether candidate genes such as FLI1, RAB31 or ADAM10 are required or sufficient for CXCL2 production and downstream neutrophil recruitment.
Conclusion
GO:2000341, regulation of chemokine (C-X-C motif) ligand 2 production, is a compact but powerful ontology term that captures the regulatory control of a central neutrophil chemoattractant. Verified studies link it to transcriptional control by Fli-1, trafficking control by RAB31, proteolytic and adhesion control by ADAM10, and metabolic control through mitochondrial fatty acid oxidation in lung injury. Because CXCL2 output shapes outcomes in ARDS, atherosclerosis, wound healing and colorectal cancer, precise perturbation of its regulators is a high-value research strategy. Combining CRISPR genome engineering with cytokine and chemotaxis readouts provides a rigorous path from candidate gene to mechanistic insight into GO:2000341.
References
- 1. Chung KP et al.. 2024. Alveolar epithelial cells mitigate neutrophilic inflammation in lung injury through regulating mitochondrial fatty acid oxidation.. Nat Commun 15(1):7241 PMID: 39174557
- 2. Qiang L et al.. 2021. Keratinocyte autophagy enables the activation of keratinocytes and fibroblastsand facilitates wound healing.. Autophagy 17(9):2128-2143 PMID: 32866426
- 3. Mulholland M et al.. 2024. Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation.. Cardiovasc Res 120(6):581-595 PMID: 38563353
- 4. Muntjewerff EM et al.. 2022. The anti-inflammatory peptide Catestatin blocks chemotaxis.. J Leukoc Biol 112(2):273-278 PMID: 34939227
- 5. Lou N et al.. 2017. The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2).. Mol Immunol 81:59-66 PMID: 27889620
- 6. Ciummo SL et al.. 2021. The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs.. Front Cell Dev Biol 9:689286 PMID: 34195201
- 7. Zong Z et al.. 2026. RAB31 orchestrates CXCL2-CXCR4-mediated neutrophil recruitment and proangiogenic niche formation in colorectal cancer.. J Transl Med 24(1) PMID: 41749320
- 8. Fuhr A et al.. 2025. Neutrophil ADAM10 promotes migration and inflammation in ARDS by modulating adhesion and chemokine signaling.. Mucosal Immunol 18(6):1353-1365 PMID: 40947020
